Authors:
Caro, JJ
O'Brien, JA
Migliaccio-Walle, K
Raggio, G
Citation: Jj. Caro et al., Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy, PHARMACOECO, 19(1), 2001, pp. 95-104
Citation: Ja. O'Brien et Jj. Caro, Alzheimer's disease and other dementia in nursing homes: Levels of management and cost, INT PSYCHOG, 13(3), 2001, pp. 347-358
Citation: Jj. Caro et K. Payne, The value of industry-sponsored studies of initial antihypertensive therapies, CAN MED A J, 164(13), 2001, pp. 1832-1832
Authors:
Caro, G
Getsios, D
Caro, JJ
Raggio, G
Burrows, M
Black, L
Citation: G. Caro et al., Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis, CEPHALALGIA, 21(1), 2001, pp. 12-19
Citation: Jj. Caro et al., Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: Evidence from randomized clinical trials, CLIN THER, 23(7), 2001, pp. 998-1017
Citation: Jj. Caro et al., Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction, STROKE, 32(1), 2001, pp. 100-106
Authors:
Caro, JJ
Getsios, D
Migliaccio-Walle, K
Raggio, G
Ward, A
Citation: Jj. Caro et al., Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care, NEUROLOGY, 57(6), 2001, pp. 964-971
Citation: D. Getsios et al., Assessment of health economics in Alzheimer's disease (AHEAD) - Galantamine treatment in Canada, NEUROLOGY, 57(6), 2001, pp. 972-978
Citation: Jj. Caro et al., Anemia as an independent prognostic factor for survival in patients with cancer - A systematic, quantitative review, CANCER, 91(12), 2001, pp. 2214-2221
Citation: Fb. Garfield et Jj. Caro, Achieving patient buy-in and long term compliance with antihypertensive treatment, DIS MANAG H, 7(1), 2000, pp. 13-20
Citation: Ja. O'Brien et al., Behavioral and psychological symptoms in dementia in nursing home residents: The economic implications, INT PSYCHOG, 12, 2000, pp. 51-57
Authors:
Caro, JJ
Flegel, KM
Orejuela, ME
Kelley, HE
Speckman, JL
Migliaccio-Walle, K
Citation: Jj. Caro et al., Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice (vol 161, pg 493, 1999), CAN MED A J, 162(7), 2000, pp. 973-973
Citation: M. Salas et al., Impact of physical functioning of health status on hospitalizations, physician visits, and costs in diabetic patients, ARCH MED R, 31(2), 2000, pp. 223-227
Authors:
Willey, C
Redding, C
Stafford, J
Garfield, F
Geletko, S
Flanigan, T
Melbourne, K
Mitty, J
Caro, JJ
Citation: C. Willey et al., Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure, CLIN THER, 22(7), 2000, pp. 858-871
Authors:
Caro, JJ
Klittich, WS
Raggio, G
Kavanagh, PL
O'Brien, JA
Shomphe, LA
Flegel, KM
Copley-Merriman, C
Sigler, C
Citation: Jj. Caro et al., Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes, CLIN THER, 22(1), 2000, pp. 116-127
Authors:
Caro, JJ
Huybrechts, KF
De Backer, G
De Bacquer, D
Closon, MC
Citation: Jj. Caro et al., Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium, ACT CARDIOL, 55(4), 2000, pp. 239-246
Authors:
Caro, JJ
Flegel, KM
Orejuela, ME
Kelley, HE
Speckman, JL
Migliaccio-Walle, K
Citation: Jj. Caro et al., Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice, CAN MED A J, 161(5), 1999, pp. 493-497